Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce®): Dual actions against respiratory bacteria

Phytomedicine

Volumn 17, Issue 8-9, 2010, Pages 563-568

  Sharma, S M ^a   Anderson, M ^b   Schoop, S R ^c   Hudson, J B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c A Vogel Bioforce AG   (Switzerland)

Author keywords

Anti bacterial; Anti inflammatory; Echinacea purpurea; Hemophilus influenza; Legionella pneumophila; MRSA; Streptococcus pyogenes

Indexed keywords

ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BRONCHUS MUCOSA; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; LEGIONELLA PNEUMOPHILA; LUNG ALVEOLUS EPITHELIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIA; CELL LINE; CYTOKINES; ECHINACEA; EPITHELIAL CELLS; HUMANS; INFECTION; INFLAMMATION; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; STREPTOCOCCUS PYOGENES;

ASTERACEAE; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ECHINACEA (ASTERACEAE); ECHINACEA PURPUREA; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; LEGIONELLA PNEUMOPHILA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM SMEGMATIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 77952287623     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.10.022     Document Type: Article

References (23)

1. Augustin A., Shahum A., Kalvsky E., Liskova A., Kisac P., and Krcmery V. Colonization of the respiratory tract by drug-resistant bacteria in HIV-infected children and prior exposure to antimicrobials. Med. Sci. Monit. 14 (2008) SC19-SC22
2. Barnes J., Anderson L.A., Gibbons S., and Phillipson J.D. Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench: a review of their chemistry,pharmacology and clinical properties. J. Pharm. Pharmacol. 57 (2005) 929-954
3. Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2 10 (2003) 66-86
4. Bauer R. Echinacea: Biological effects and active principals. Phytomedicines of Europe: chemistry and biological activity. In: Lawson L.D., and Bauer R. (Eds). ACS Symposium Series 691 (1998), American Chemical Society, Washington, DC 140-157
5. Beisswenger C., Lysenko E.S., and Weiser J.N. Early bacterial colonization induces toll like receptor-dependent transforming growth factor ß signaling in the epithelium. Infec. Immun 77 (2009) 2212-2220
6. Diederen B.M.W. Legionella spp. and Legionnaires' disease. J. Infect. 56 (2008) 1-12
7. Diep B.A., and Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16 (2008) 361-369
8. Erwin A.L., and Smith A.L. Nontypeable Hemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol. 15 (2007) 355-362
9. Hudson J., Vimalanathan S., Kang L., Treyvaud Amiguet V., Livesey J., and Arnason J.T. Characterization of antiviral activities in Echinacea root preparations. Pharmac. Biol. 43 (2005) 790-796
10. Isberg R.R., O-Connor T.J., and Heidtman M. The Legionella pneumophila replication vacuole; making a cosy niche inside host cells. Nat. Rev. Microbiol. 7 (2009) 23-34
11. Merali S., Binns S., Paulin-Levasseur M., Ficker C., Smith. M., Baum B.R., and Arnason J.T. Antifungal and anti-inflammatory activity of the genus Echinacea. Pharmac. Biol. 41 (2003) 412-420
12. Niki Y., (79 co-authors), et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: A general view of antibacterial susceptibility. J. Infect. Chemother. 14 (2008) 279-290
13. Roxas M., and Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern. Med. Rev. 12 (2007) 25-48
14. Rubinstein E., Kollet M.H., and Nathwani D. Pneumonia caused by Methicillin-resistant Staphylococcus aureus. Clin. Infec. Dis. 46 (2008) S378-S385
15. Schoop R., Klein P., Suter A., and Johnston S.L. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin. Therapeutics 28 (2006) 174-183
16. Sharma M., Vohra S., Arnason J.T., and Hudson J.B. Echinacea extracts contain significant and selective activities against human pathogenic bacteria. Pharmac. Biol. 46 1-2 (2008) 111-116
17. Sharma M., Schoop R., and Hudson J.B. Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Phytother. Res. 23 (2008) 863-867
18. Sharma M., Anderson S.A., Schoop R., and Hudson J.B. Induction of pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiv. Res. 83 (2009) 165-170
19. Tart A.H., Walker M.J., and Musser J.M. New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol. 15 (2007) 318-325
20. Tsai P.J., Chen Y.H., Hsueh C.H., Hsieh H.C., Liu Y.H., Wu J.J., and Tsou C.C. Streptococcus pyogenes induces epithelial inflammatory responses through NF-kB/MAPK signaling pathways. Microb. Infect. 8 (2006) 1440-1449
21. Vohra S., Adams D., Hudson J.B., Moore J.A., Vimalanathan S., Sharma M., Burt A., Lamont E., Lacaze N., Arnason J.T., and Lee T.D.G. Selection of natural health products for clinical trials: a preclinical template can. J. Physiol. Pharmacol. 87 (2009) 371-378
22. Wang S.M., Lu I.H., Lin Y.L., Lin Y.S., Wu J.J., Chuang W.J., Lin M.T., and Liu C.C. The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diag. Microbiol. Infect. Dis. 61 (2008) 165-169
23. Wang J.H., Kwon H.J., and Jang Y.J. Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously. Laryngosc. (2009) 10.1002/lary-20498